Ranibizumab treat and extend for neovascular age-related macular degeneration (AMD) - One-year outcomes

被引：0
|
作者：
Trivedi, Dipti [1 ]
Alfaqawi, Fadi [1 ]
Lip, Peck Lin [1 ]
Mushtaq, Bushra [1 ]
Chavan, Randhir [1 ]
机构：
[1] Birmingham & Midland Eye Ctr, Birmingham, W Midlands, England
来源：
EYE | 2018年 / 32卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
RF10
引用
收藏
页码：20 / 23
页数：4
相关论文
共 50 条
  • [21] Ranibizumab for neovascular age-related macular degeneration
    Rosenfeld, Philip J.
    Brown, David M.
    Heier, Jeffrey S.
    Boyer, David S.
    Kaiser, Peter K.
    Chung, Carol Y.
    Kim, Robert Y.
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (14): : 1419 - 1431
  • [22] Ranibizumab for neovascular age-related macular degeneration
    Hernandez-Pastor, Luis Javier
    Ortega, Ana
    Garcia-Layana, Alfredo
    Giraldez, Joaquin
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (19) : 1805 - 1814
  • [23] Ranibizumab for neovascular age-related macular degeneration
    Gillies, Mark C.
    Wong, Tien Y.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (07): : 748 - 749
  • [24] One-Year Outcomes Using Ranibizumab for Neovascular Age-Related Macular Degeneration: Results of a Prospective and Retrospective Observational Multicentre Study
    Hjelmqvist, Lars
    Lindberg, Charlotte
    Kanulf, Par
    Dahlgren, Henrik
    Johansson, Ingrid
    Siewert, Annica
    JOURNAL OF OPHTHALMOLOGY, 2011, 2011
  • [25] Ranibizumab in neovascular age-related macular degeneration
    Eng, Kenneth T.
    Kertes, Peter J.
    CLINICAL INTERVENTIONS IN AGING, 2006, 1 (04) : 451 - 466
  • [26] PROSPECTIVE ONE-YEAR STUDY OF RANIBIZUMAB FOR PREDOMINANTLY HEMORRHAGIC CHOROIDAL NEOVASCULAR LESIONS IN AGE-RELATED MACULAR DEGENERATION
    Chang, Margaret A.
    Do, Diana V.
    Bressler, Susan B.
    Cassard, Sandra D.
    Gower, Emily W.
    Bressler, Neil M.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2010, 30 (08): : 1171 - 1176
  • [27] One-Year Outcomes of Aflibercept in Recurrent or Persistent Neovascular Age-Related Macular Degeneration REPLY
    Arcinue, Cheryl A.
    Ma, Feiyan
    Barteselli, Giulio
    Sharpsten, Lucie
    Gomez, Maria Laura
    Freeman, William R.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2015, 159 (05) : 997 - 997
  • [28] One-year results of intravitreal ranibizumab for neovascular age-related macular degeneration and clinical responses of various subgroups
    Seungbum Kang
    Young-Jung Roh
    Japanese Journal of Ophthalmology, 2009, 53 : 389 - 395
  • [29] One-year results of intravitreal ranibizumab for neovascular age-related macular degeneration and clinical responses of various subgroups
    Kang, Seungbum
    Roh, Young-Jung
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2009, 53 (04) : 389 - 395
  • [30] Comparison of Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration According to LUCAS Treat-and-Extend Protocol
    Berg, Karina
    Pedersen, Terje R.
    Sandvik, Leiv
    Bragadottir, Ragnheidur
    OPHTHALMOLOGY, 2015, 122 (01) : 146 - 152
12345